Bayer is signaling it has had enough of litigation, leaving the future of a crop protection tool in limbo.
Executives tell the Wall Street Journal they are nearing the end of the road for glyphosate, the main ingredient in RoundUp. CEO Bill Anderson says they are barely breaking even, and litigation costs often put them in the red.
More than 65,000 cases are pending against Bayer right now, and the company has around $16 billion set aside for settlements.
Anderson stands by glyphosate, saying it has been proven safe to use, even by the FDA. Bayer produces roughly 40 percent of the supply used by U.S. farmers.
Related Stories
The bill has already cleared the House Agriculture Committee and is headed toward a full House vote, but the timeline for final passage remains unclear. But the question is, when exactly? Could it possibly be a nice little gift for Easter?
Tidal Grow’s AlignN delivers encapsulated nitrogen to leaves, boosting in-season response, yield gains, and farm profits.
Jake Charleston of Specialty Risk Insurance offers his perspective on current cattle market conditions and shares advice for producers seeking to stay protected in an uncertain market.
Leadership continuity signals a steady focus on family farm advocacy.
National Pork Producers Council incoming president Rob Brenneman shares insights from the National Pork Industry Forum in Kansas City, where producers gathered to discuss Farm Bill policy, sustainability, and other priorities for the year ahead.
Partnership with U.S. Army Corps of Engineers Ensures Engineering Excellence and Operational Effectiveness
